Sign Out
Clear to slightly opalescent, colourless to pale brown liquid.
Each mL of concentrate contains 25 mg of bevacizumab*.
Each 4 mL vial contains 100 mg of bevacizumab.
Each 16 mL vial contains 400 mg of bevacizumab.
For dilution and other handling recommendations, see Special precautions for disposal and other handling under Cautions for Usage.
*Bevacizumab is a recombinant humanised monoclonal antibody produced by DNA technology in Chinese Hamster Ovary cells.
Excipient with known effect: Each 4 mL vial contains 1.6 mg of polysorbate 20.
Each 16 mL vial contains 6.4 mg of polysorbate 20.
Excipients/Inactive Ingredients: Trehalose dihydrate, Sodium phosphate, Polysorbate, Water for injections.
Continue with Google